Peripheral Neuropathy Trial, Recruiting NCT05395715 Sponsor: University of Alberta Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT05395715
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have signs and symptoms of severe cubital tunnel syndrome (a condition where the nerve at the elbow is compressed), classified as a specific advanced stage known as McGowan-Goldberg grade 3
  • People whose nerve testing (using a needle to measure electrical activity in the muscles) shows signs of long-term nerve damage and reduced muscle activity in the small muscles of the hand controlled by the ulnar nerve (the nerve that runs along the inner elbow)
  • People whose nerve electrical testing shows severe loss of working nerve fibres, measured by a specific test called motor unit number estimation (MUNE), with results falling significantly below the normal range

Who may not be able to join:

  • People who have another nerve injury happening at the same time
  • People who have previously had surgery for cubital tunnel syndrome
  • People who have another existing neurological (nervous system) condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (780) 492-1614

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2022
Est. completion
31 March 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Motor unit number estimation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov